DOCSLIB.ORG

Physician Sample.Fm

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Physician Sample.Fm Tabular List Endocrine, Nutritional and Metabolic Diseases, and Immunity 240–244.9 Endocrine, Nutritional and Metabolic Nutritional Endocrine, 3. Endocrine, Nutritional and Metabolic Diseases, The Endocrine System Hypothalamus and Immunity Disorders(240-279) Pituitary Pineal gland (Hypophysis) 2 endocrine and metabolic disturbances specific to the fetus gland Parathyoid and newborn (775.0-775.9) Thyroid gland glands NOTE All neoplasms, whether functionally active or not, are classified in Chapter 2. Codes in Chapter 3 (i.e., 242.8, 246.0, 251-253, Thymus gland 255-259) may be used to identify such functional activity associated with any neoplasm, or by ectopic endocrine tissue. Adrenal Disorders of Thyroid Gland (240-246) (Suprarenal) Ovaries glands b 240 Simple and unspecified goiter Pancreas DEF: An enlarged thyroid gland often caused by an inadequate dietary intake of iodine. Testes 240.0 Goiter, specified as simple Any condition classifiable to 240.9, specified as simple § c 242.3 Toxic nodular goiter, unspecified 240.9 Goiter, unspecified [0-1] Adenomatous goiter Enlargement of thyroid Nodular goiter toxic or with hyperthyroidism Immunity and Diseases, 240–244.9 Goiter or struma: Struma nodosa NOS diffuse colloid Any condition classifiable to 241.9 specified as toxic or with endemic hyperthyroidism hyperplastic § c 242.4 Thyrotoxicosis from ectopic thyroid nodule nontoxic (diffuse) [0-1] parenchymatous sporadic § c 242.8 Thyrotoxicosis of other specified origin 2 congenital (dyshormonogenic) goiter (246.1) [0-1] Overproduction of thyroid-stimulating hormone [TSH] Thyrotoxicosis: b 241 Nontoxic nodular goiter factitia from ingestion of excessive thyroid material 2 adenoma of thyroid (226) Use additional E code to identify cause, if drug-induced cystadenoma of thyroid (226) § c 242.9 Thyrotoxicosis without mention of goiter or other 241.0 Nontoxic uninodular goiter [0-1] cause Thyroid nodule Hyperthyroidism NOS Uninodular goiter (nontoxic) Thyrotoxicosis NOS DEF: Enlarged thyroid, commonly due to decreased thyroid E05.90 Thyrotoxicosis uns w/o thyrotoxic crisis or storm I-10 production, with single nodule; no clinical hypothyroidism. E04.1 Nontoxic single thyroid nodule I-10 243 Congenital hypothyroidism Congenital thyroid insufficiency 241.1 Nontoxic multinodular goiter Cretinism (athyrotic) (endemic) Multinodular goiter (nontoxic) DEF: Enlarged thyroid, commonly due to decreased thyroid Use additional code to identify associated mental retardation production with multiple nodules; no clinical hypothyroidism. 2 congenital (dyshormonogenic) goiter (246.1) DEF: 241.9 Unspecified nontoxic nodular goiter Underproduction of thyroid hormone present from birth. Adenomatous goiter b 244 Acquired hypothyroidism Nodular goiter (nontoxic) NOS 1 athyroidism (acquired) Struma nodosa (simplex) hypothyroidism (acquired) b 242 Thyrotoxicosis with or without goiter myxedema (adult) (juvenile) thyroid (gland) insufficiency (acquired) 2 neonatal thyrotoxicosis (775.3) DEF: A condition caused by excess quantities of thyroid hormones being 244.0 Postsurgical hypothyroidism introduced into the tissues DEF: Underproduction of thyroid hormone due to surgical removal of The following fifth-digit subclassification is for use with categories 242: all or part of the thyroid gland. 0 without mention of thyrotoxic crisis or storm E89.0 Postprocedural hypothyroidism I-10 1 with mention of thyrotoxic crisis or storm 244.1 Other postablative hypothyroidism Hypothyroidism following therapy, such as irradiation § c 242.0 Toxic diffuse goiter [0-1] Basedow's disease 244.2 Iodine hypothyroidism Exophthalmic or toxic goiter NOS Hypothyroidism resulting from administration or ingestion of Graves' disease iodide Primary thyroid hyperplasia Use additional E code to identify drug DEF: Diffuse thyroid enlargement accompanied by hyperthyroidism, bulging eyes, and dermopathy. 244.3 Other iatrogenic hypothyroidism Hypothyroidism resulting from: § c 242.1 Toxic uninodular goiter P-aminosalicylic acid [PAS] [0-1] Thyroid nodule toxic or with hyperthyroidism Phenylbutazone Uninodular goiter Resorcinol DEF: Symptomatic hyperthyroidism with a single nodule on the Iatrogenic hypothyroidism NOS enlarged thyroid gland. Abrupt onset of symptoms; including extreme nervousness, insomnia, weight loss, tremors, and psychosis Use additional E code to identify drug or coma. 244.8 Other specified acquired hypothyroidism § 242.2 Toxic multinodular goiter Secondary hypothyroidism NEC c AHA: [0-1] Secondary thyroid hyperplasia J-A, ‘85, 9 DEF: Symptomatic hyperthyroidism with multiple nodules on the 244.9 Unspecified hypothyroidism enlarged thyroid gland. Abrupt onset of symptoms; including Hypothyroidism primary or NOS extreme nervousness, insomnia, weight loss, tremors, and psychosis Myxedema or coma. AHA: 3Q, ‘99, 19; 4Q, ‘96, 29 E03.9 Hypothyroidism unspecified I-10 b c Additional Digit Required Unspecified Code Other Specified Code Manifestation Code wx Revised Text l New Code s Revised Code Title 2011 ICD-9-CM Volume 1 – 1 424–425.5 Diseases of the Circulatory System Tabular List 7. Diseases of the Circulatory System (390-459) 424.3 Pulmonary valve disorders Pulmonic: Pulmonic: b 424 Other diseases of endocardium incompetence NOS regurgitation NOS insufficiency NOS stenosis NOS 2 bacterial endocarditis (421.0-421.9) rheumatic endocarditis (391.1, 394.0-397.9) 2 that specified as rheumatic (397.1) syphilitic endocarditis (093.20-093.24) c 424.9 Endocarditis, valve unspecified 424.0 Mitral valve disorders 424.90 Endocarditis, valve unspecified, unspecified Mitral (valve): cause incompetence NOS of specified cause, Endocarditis (chronic): insufficiency except rheumatic NOS regurgitation nonbacterial thrombotic 2 mitral (valve): Valvular: disease (394.9) incompetence failure (394.9) insufficiency of unspecified valve, stenosis (394.0) regurgitation unspecified cause the listed conditions: stenosis specified as rheumatic (394.1) Valvulitis (chronic) unspecified as to cause but with mention of: I38 Endocarditis valve unspecified I-10 diseases of aortic valve (396.0-396.9) 424.91 Endocarditis in diseases classified elsewhere mitral stenosis or obstruction (394.2) AHA: 3Q, ’06, 7; 2Q, ‘00, 16; 3Q, ‘98, 11; N-D, ‘87, 8; N-D, ‘84, 8 Code first underlying disease as: I34.8 Other nonrheumatic mitral valve disorders I-10 atypical verrucous endocarditis [Libman-Sacks] (710.0) 424.1 Aortic valve disorders disseminated lupus erythematosus (710.0) Aortic (valve): tuberculosis (017.9) incompetence syphilitic (093.20-093.24) insufficiency NOS of specified cause, 2 regurgitation except rheumatic 424.99 Other stenosis Any condition classifiable to 424.90 with specified 2 hypertrophic subaortic stenosis (425.1) cause, except rheumatic that specified as rheumatic (395.0-395.9) 2 endocardial fibroelastosis (425.3) that of unspecified cause but with mention of diseases that specified as rheumatic (397.9) of mitral valve (396.0-396.9) b 425 Cardiomyopathy AHA: 4Q, ‘08, 179; 4Q, ‘88, 8; N-D, ‘87, 8 1 myocardiopathy 424.2 Tricuspid valve disorders, specified as nonrheumatic AHA: J-A, ‘85, 15 Tricuspid valve: incompetence 425.0 Endomyocardial fibrosis insufficiency of specified cause, except 425.1 Hypertrophic obstructive cardiomyopathy regurgitation rheumatic Hypertrophic subaortic stenosis (idiopathic) stenosis DEF: Cardiomyopathy marked by left ventricle hypertrophy, enlarged 2 rheumatic or of unspecified cause (397.0) septum; results in obstructed blood flow. 425.2 Obscure cardiomyopathy of Africa Becker's disease Heart Valve Disorders Idiopathic mural endomyocardial disease 425.3 Endocardial fibroelastosis 424–425.5System of the Circulatory Diseases Elastomyofibrosis Incompetent valve DEF: A condition marked by left ventricle hypertrophy and (trouble closing) conversion of the endocardium into a thick fibroelastic coat; capacity causes regurgitation of the ventricle may be reduced, but is often increased. Valve stenosis (backflow of blood) (trouble opening) 425.4 Other primary cardiomyopathies Cardiomyopathy: Cardiomyopathy: NOS idiopathic Insufficient valve congestive nonobstructive (unable to close completely) constrictive obstructive Shortened, fused familial restrictive chorda tendinae hypertrophic Cardiovascular collagenosis Ventricular hypertrophy AHA: w4Q, ’09, 141;x 1Q, ‘07, 20; 2Q, ’05, 14; 1Q, ‘00, 22; 4Q, ‘97, 55; 2Q, ‘90, 19 Normal Heart Valve Function TIP: For congestive cardiomyopathy, assign first a code for the CHF (category 428) if the treatment is directed toward the CHF. Atrium I42.8 Other cardiomyopathies I-10 contracts Great Valve leaflet artery 425.5 Alcoholic cardiomyopathy (cusp) (aorta or DEF: Heart disease as result of excess alcohol consumption. Chorda pulmonary AHA: S-O, ‘85, 15 tendinae artery) 425.7 Nutritional and metabolic cardiomyopathy Papillary Ventricle fills Great vein muscle (vena cava or Code first underlying disease, as: pulmonary vein) amyloidosis (277.30-277.39) Atrium fills beriberi (265.0) cardiac glycogenosis (271.0) Ventricle mucopolysaccharidosis (277.5) contracts Great artery (blood to body thyrotoxicosis (242.0-242.9) or lungs) 2 gouty tophi of heart (274.82) 8 Newborn Age: 0 9 Pediatric Age: 0-17 x Maternity Age: 12-55 y Adult Age: 15-124 2 – Volume 1 2011 ICD-9-CM Tabular List Diseases of the Circulatory System 425.9–426.9 Diseases of the Circulatory System System of the Circulatory Diseases 425.9–426.9 425.8 Cardiomyopathy in other diseases classified elsewhere Normal and Long QT Electrocardiogram Code first underlying disease, as: QRS Friedreich's
Load more

Recommended publications
  • Clinical Significance of Exit Block*
    Clinical Significance of Exit Block* IRANY M. DE AZEVEDO, M.D. YOSHIO WATANABE, M.D. LEONARD S. DREIFUS, M.D. From the Departments of Medicine, Physiology, and Biophysics, Hahnemann Medical College, Philadelphia, Pennsylvania The confinement of an ectopic discharge to its ily reserved for ectopic pacemakers, rather than the focus, and its consequent inability to invade the ad­ sinus node. jacent myocardium when falling outside of the re­ High Grade Atrioventricular Block. In vi rtu­ fractory period of the heart, is a well established ally all instances, exit block occurs in the presence phenomenon called "exit block." This cardiac ar­ of higher degrees of A-V block. Failure of the rhythmia was originally described by Kaufmann impulse to propagate from the subsidiary ectopic and Rothberger ( 8) to explain the failure of a para­ focus to either the ventricles, atria, or both is char­ systolic focus to activate the heart. All pacemakers acteristic of this form of exit block. Several exam­ are subject to exit block (9, 13, 15, 14, 11 , 16, 12, ples are illustrated. In figure 2, there is high grade 3, 10, 7, 1), however, by convention, conduction A-V block causing A-V dissociation. The atria are disturbances involving the sinus node (S-A block) under the control of the sinus node at a rate of 71 are usually excluded from this concept, and the term per minute, and the ventricles are controlled by a is reserved for ectopic pacemakers. Recent electro­ subsidiary ectopic pacemaker, probably originating physiological and clinical studies have shown that in the right bundle branch at a rate of approximately exit block may complicate reentrant arrhythmias and 40 per minute.
    [Show full text]
  • Spontaneous Resolution of Sinoatrial Exit Block and Atrioventricular Dissociation in a Child with Dengue Fever Kaushik J S, Gupta P, Rajpal S, Bhatt S
    Case Report Singapore Med J 2010; 51(9) : e146 Spontaneous resolution of sinoatrial exit block and atrioventricular dissociation in a child with dengue fever Kaushik J S, Gupta P, Rajpal S, Bhatt S ABSTRACT her heart rate was regular at 92/min, respiratory rate at Cardiac rhythm abnormalities, including 22/min and blood pressure (BP) at 110/74 mmHg. There ventricular arrhythmia, atrial fibrillation and was a petechial rash over the patient’s back, trunk and atrioventricular block, have been observed upper extremities. The Hess test (tourniquet test) for during the acute stage of dengue haemorrhagic capillary fragility was positive. Systemic examination fever. Atrioventricular or complete heart did not reveal any abnormality. block can be fatal and may require a temporary Investigations revealed normal haemoglobin (12.1 pacemaker. We report a ten-year-old girl who g/dl), haematocrit (35.2%) and leucocyte (6500/cumm) presented with dengue haemorrhagic fever counts, while the platelet count was observed to be with sinoatrial block and atrioventricular low (38000/cumm). Dengue serology was reactive dissociation that had a spontaneous resolution. for immunoglobulin G (IgG) and immunoglobulin M (IgM), suggesting acute primary infection. The liver Keywords: atrioventricular block, enzymes and renal profile, including serum electrolytes, atrioventricular dissociation, dengue were normal. The patient was managed supportively haemorrhagic fever, rhythm abnormality, according to the World Health Organization (WHO) sinoatrial block recommendations for management of dengue Singapore Med J 2010; 51(8): e146-e148 haemorrhagic fever.(3) The following day, the patient was observed to have INTRODUCTION bradycardia (pulse rate 50/min, regular), with normal Dengue fever is a viral infection that is transmitted BP.
    [Show full text]
  • Cardiac Arrhythmia
    Cardiac Arrhythmia How to approach นพ.พินิจ แกวสุวรรณะ หน่วยโรคหัวใจและหลอดเลือด EKG paper is a grid where time is measured along the horizontal axis. Each small square is 1 mm in length and represents 0.04 seconds. Each larger square is 5 mm in length and represents 0.2 seconds. Voltage is measured along the vertical axis Voltage is measured along the vertical axis. 10 mm is equal to 1mV in voltage. The diagram below illustrates the configuration of EKG graph paper and where to measure the components of the EKG wave form P wave Indicates atrial depolarization, or contraction of the atrium. Normal duration is not longer than 0.11 seconds (less than 3 small squares) Amplitude (height) is no more than 3 mm No notching or peaking QRS complex Indicates ventricular depolarization, or contraction of the ventricles. Normally not longer than .10 seconds in duration Amplitude is not less than 5 mm in lead II or 9 mm in V3 and V4 R waves are deflected positively and the Q and S waves are negative T wave Indicates ventricular repolarization Not more that 5 mm in amplitude in standard leads and 10 mm in precordial leads Rounded and asymmetrical ST segment Indicates early ventricular repolarization Normally not depressed more than 0.5 mm May be elevated slightly in some leads (no more than 1 mm) PR interval Indicates AV conduction time Duration time is 0.12 to 0.20 seconds QT interval Indicates repolarization time General rule: duration is less than half the preceding R-R interval Sinus Bradycardia Rate40-59 bpm P wavesinus QRSnormal (.06-.12) ConductionP-R normal or slightly prolonged at slower rates Rhythmregular or slightly irregular This rhythm is often seen as a normal variation in athletes, during sleep, or in response to a vagal maneuver.
    [Show full text]
  • Cardiac Rhythms and Arrhythmias Chapter 12 Sinus Node Dysfunction
    SECTION II Cardiac Rhythms and Arrhythmias Chapter 12 Sinus Node Dysfunction SAROJA BHARATI, NORA GOLDSCHLAGER, FRED KUSUMOTO, RALPH LAZZARA, RABIH AZAR, STEPHEN HAMMILL, and GERALD NACCARELLI Epidemiology: Nora Goldschlager, Fred Kusumoto, and Rabih Azar Anatomy and Pathology: Saroja Bharati Basic Electrophysiology: Ralph Lazzara Etiology: Nora Goldschlager, Fred Kusumoto, and Rabih Azar Diagnostic Evaluation: Gerald Naccarelli Clinical Electrophysiology: Stephen Hammill Evidence-Based Therapy: Nora Goldschlager, Fred Kusumoto, and Rabih Azar In the early 1900s Keith and Flack identified the sinus due to the decrease in vagal tone that occurs with node as the region responsible for activation of the increasing age. heart.1 Laslett first suggested sinus node dysfunction as Sinus node dysfunction should be suspected when a a cause of bradycardia in 1909, and during the 1950s patient describes symptoms of fatigue, syncope or pre- and 1960s Short, Ferrer, Lown, and others described syncope, or exercise intolerance and is noted to have the clinical spectrum of sinus node dysfunction that is sinus bradycardia or pauses on the 12-lead ECG or dur- commonly called the “sick sinus syndrome resting sinus ing Holter monitoring. In general, symptomatic sinus bradycardia.”2-5 Sinus node dysfunction can have multi- node dysfunction increases with age, with the incidence ple electrocardiographic manifestations including sinus doubling between the fifth and sixth decades of life. pauses, the bradycardia-tachycardia syndrome, and inap- In one study of approximately 9000 patients visiting propriate sinus node response to exercise (chronotropic a regional cardiac center in Belgium, Kulbertus et al. incompetence). estimated that the incidence of sinus node dysfunction is less than 5 per 3000 people older than 50 years of age.9 However, sinus node dysfunction is more com- Epidemiology monly identified today because of an increased elderly population and increased physician awareness.
    [Show full text]
  • View Pdf Copy of Original Document
    Phenotype definition for the Vanderbilt Genome-Electronic Records project Identifying genetics determinants of normal QRS duration (QRSd) Patient population: • Patients with DNA whose first electrocardiogram (ECG) is designated as “normal” and lacking an exclusion criteria. • For this study, case and control are drawn from the same population and analyzed via continuous trait analysis. The only difference will be the QRSd. Hypothetical timeline for a single patient: Notes: • The study ECG is the first normal ECG. • The “Mildly abnormal” ECG cannot be abnormal by presence of heart disease. It can have abnormal rate, be recorded in the presence of Na-channel blocking meds, etc. For instance, a HR >100 is OK but not a bundle branch block. • Y duration = from first entry in the electronic medical record (EMR) until one month following normal ECG • Z duration = most recent clinic visit or problem list (if present) to one week following the normal ECG. Labs values, though, must be +/- 48h from the ECG time Criteria to be included in the analysis: Criteria Source/Method “Normal” ECG must be: • QRSd between 65-120ms ECG calculations • ECG designed as “NORMAL” ECG classification • Heart Rate between 50-100 ECG calculations • ECG Impression must not contain Natural Language Processing (NLP) on evidence of heart disease concepts (see ECG impression. Will exclude all but list below) negated terms (e.g., exclude those with possible, probable, or asserted bundle branch blocks). Should also exclude normalization negations like “LBBB no longer present.”
    [Show full text]
  • IHEU-IHES-IHP Front Matter
    IHEU unique 7/13/06 12:03 PM Page i 2007 ICD-9-CM Expert for Hospitals Volumes 1, 2 & 3 International Classification of Diseases 9th Revision Clinical Modification Sixth Edition Edited by: Anita C. Hart, RHIA, CCS, CCS-P Beth Ford, RHIT, CCS Ingenix is committed to providing you with the ICD-9-CM code update information you need to code accurately and to be in compliance with HIPAA regulations. In the case of adoption of additional ICD-9-CM code changes effective April 1, 2007, Ingenix will provide these code changes to you at no additional cost! Just check back at http://www.IngenixOnline.com and look for the ICD-9, CPT® and HCPCS Alerts link under the Quick Access Resources menu to review the latest information concerning any new code changes. Codes Valid October 1, 2006, through September 30, 2007 October 2006 Update 3539/IHEU/U0515 07 ICD9 v1 H 7/11/06 2:24 PM Page 127 Tabular List CIRCULATORY SYSTEM 425.8–426.89 Circulatory System 425.8–426.89 Nerve Conduction of the Heart Normal and Long QT Electrocardiogram QRS Interval ST Interval Normal Long QT R Syndrome R PR Sinoatrial node Segment QT Interval QT Interval (pacemaker) Bachmannʼs bundle PR ST Interval Segment Internodal tracts: Anterior T Middle P T P Posterior Left bundle branch block Left bundle branch: Atrioventricular Q node Anterior fascicle Q Common bundle Posterior fascicle S (of His) S Left bundle branch Atrioventricular block hemiblock 0.2.4.6 0.2.4.6 Accessory bundle MC (of Kent) 426.3 ¥>Other left bundle branch block Right bundle branch Left bundle branch block: Right
    [Show full text]
  • Adams-Stokes Syndrome Caused by Sinoatrial Block
    Br Heart J: first published as 10.1136/hrt.35.10.1002 on 1 October 1973. Downloaded from British Heart Journal, 1973, 35, I002-I008. Adams-Stokes syndrome caused by sinoatrial block Bjarne Sigurd, Gorm Jensen, J0rgen Meibom, and Erik Sand0e From Medical Department B, Rigshospitalet, University of Copenhagen, Denmark Forty-six patients with syncope and/or black-out episodes due to sinoatrial block are presented. Male-to- female ratio was i to i, and mean age at onset of symptoms approximately 63 years in both sexes. Additional heart disease, especially coronary artery disease, was frequently, but not constantly, found. Twenty-five per cent had sinus node dysfunction as the only manifestation of cardiac disease. Ninety per cent had frequent paroxysms of one or several types of a wide spectrum of supraventricular dysrhythmias, which often gave rise to troublesome symptoms in the form of palpitation, fatigue, and/or congestion, but also made it easier to recognize the cardiac origin of the unspecific cerebral symptoms. Cerebral symptoms occurred suddenly and unexpectedly, and often disabled the patients to a severe degree. Drug treatment proved of little value, but pacemaker treatment stopped the cerebral attacks in all the 39 cases in which it was performed. In 3 out of 24 patients pacemaker implantation also abolished the tendency for paroxysms of tachydysrhythmias; in the remaining 2I it allowedfor maximal drug treatment which led to nearly total relieffrom tachydysrhythmias in 17. copyright. Attacks of third-degree sinoatrial block, resulting in Patients cerebral ischaemic symptoms, account for I0 to 20 There were 46 patients with a chronic, intermittent per cent of all cases, in which artificial pacemakers tendency to syncope and/or black-out episodes, assumed are considered necessary (Rasmussen, 197I; Jen- to be caused by paroxysms of third-degree sinoatrial sen et al., I973).
    [Show full text]
  • Sinus Bradycardia
    British Heart Journal, I97I, 33, 742-749. Br Heart J: first published as 10.1136/hrt.33.5.742 on 1 September 1971. Downloaded from Sinus bradycardia Dennis Eraut and David B. Shaw From the Cardiac Department, Royal Devon and Exeter Hospital, Exeter, Devon This paper presents thefeatures of 46 patients with unexplained bradycardia. Patients were ad- mitted to the study if their resting atrial rate was below 56 a minute on two consecutive occasions. Previous electrocardiograms and the response to exercise, atropine, and isoprenaline were studied. The ages of thepatients variedfrom I3 to 88years. Only 8 had a past history ofcardiovascular disease other than bradycardia, but 36 hJd syncopal or dizzy attacks. Of the 46 patients, 35 had another arrhythmia in addition to bradycardia; at some stage, i6 had sinus arrest, i.5 hadjunc- tional rhythm, 12 had fast atrial arrhythmia, I6 had frequent extrasystoles, and 6 had atrio- ventricular block. None had the classical features of sinoatrial block. Arrhythmias were often produced by exercise, atropine, or isoprenaline. Drug treatment was rarely satisfactory, but only i patient needed a permanent pacemaker. It is suggested that the majority of the patients were suffering from a pathological form of sinus bradycardia. The aetiology remains unproven, but the most likely explanation is a loss of the inherent rhythmicity of the sinoatrial node due to a primary degenerative disease. The descriptive title of 'the lazy sinus syndrome' is suggested. copyright. Bradycardia with a slow atrial rate is usually attempt to define the clinical syndrome of regarded as an innocent condition common in bradycardia with a pathologically slow atrial certain types of well-trained athlete, but occa- rate and to clarify the nature of the arrhyth- sionally it may occur in patients with symp- mia.
    [Show full text]
  • Dysrhythmias
    CARDIOVASCULAR DISORDERS DYSRHYTHMIAS I. BASIC PRINCIPLES OF CARDIAC CONDUCTION DISTURBANCES A. Standard ECG and rhythm strips 1. Recordings are obtained at a paper speed of 25 mm/sec. 2. The vertical axis measures distance; the smallest divisions are 1 mm ×1 mm. 3. The horizontal axis measures time; each small division is 0.04 sec/mm. B. Normal morphology Courtesy of Dr. Michael McCrea 1. P wave = atrial depolarization a. Upright in leads I, II, III, aVL, and aVF; inverted in lead aVR b. Measures <0.10 seconds wide and <3 mm high c. Normal PR interval is 0.12–0.20 seconds. 2. QRS complex = ventricular depolarization a. Measures 0.06-0.10 seconds wide b. Q wave (1) <0.04 seconds wide and <3 mm deep (2) Abnormal if it is >3 mm deep or >1/3 of the QRS complex. c. R wave ≤7.5 mm high 3. QT interval varies with rate and sex but is usually 0.33–0.42 seconds; at normal heart rates, it is normally <1/2 the preceding RR interval. 4. T wave = ventricular repolarization a. Upright in leads I, II, V3–V6; inverted in aVR b. Slightly rounded and asymmetric in configuration c. Measures ≤5 mm high in limb leads and ≤10 mm high in the chest leads 5. U wave = a ventricular afterpotential a. Any deflection after the T wave (usually low voltage) b. Same polarity as the T wave c. Most easily detected in lead V3 d. Can be a normal component of the ECG e. Prominent U waves may indicate one of the following: (1) Hypokalemia (<3 mEq/L) (2) Hypercalcemia (3) Therapy with digitalis, phenothiazines, quinidine, epinephrine, inotropic agents, or amiodarone (4) Thyrotoxicosis f.
    [Show full text]
  • Effects of Selective Site Pacing on Haemodynamic and Functional Recovery in Patients Requiring Permanent Right Ventricular Pacing
    Effects of Selective Site Pacing on Haemodynamic and Functional Recovery in Patients Requiring Permanent Right Ventricular Pacing Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor of Medicine by Klialed Albouaini 2011 Liverpool Heart and Chest Hospital NHS Trust Thomas Drive Liverpool L14 3PE Effects of Selective Site Pacing on Haemodynamic and Functional Recovery in Patients Requiring Permanent Right Ventricular Pacing. (International Standard Randomised Controlled Trial Registration Number: ISRCTN 67629267) The single centre randomised trial aimed to assess whether right ventricular outflow tract (RVOT) compared to right ventricular apical (RVA) pacing is more beneficial at the medium term follow-up. Fifty patients were randomised to either RVA (n—25) or RVOT (n=25) pacing. Baseline and 6 month follow-up investigations included: electrocardiogram, New York heart failure functional (NYHA) class, Minnesota Living with Heart Failure (MLWHF) score. Short Form-36 health survey (SF-36), echocardiogram, and a cardiopulmonary exercise test. The primary endpoint was peak oxygen consumption (PVO2). Secondary endpoints were: NYHA class, MLWHF and SF-36 scores, LVEF, and dyssynchrony criteria. There were no significant differences in changes in PVO2 levels between the study groups. Similarly, QRS duration changes were not significantly different between the study groups. In contrast, MLWHF scores improved significantly in the RVOT group (32 ± 19) compared with the RVA group (21 ± 22), P=0.041. In addition, SF-36 health survey indicated better scores in RVOT patients in the following areas: (1) Physical Function, 36.6 ± 28.0 (RVOT) versus 11.2 ± 26.0 (RVA), P = 0.005; (2) Role Limitation due to Emotional Problem scores, 43.3 ± 9.7 (RVOT) versus 4.5 ±11.6 (RVA arm), P = 0.016; (3) Vitality Energy Fatigue scores 26.3 ± 27.0 (RVOT) versus 7.2 ± 24.0 (RVA), P = 0.024.
    [Show full text]
  • The Evaluation of Sinoatrial Node Function 1N Man*
    The Evaluation of Sinoatrial Node Function 1n Man* J. THOMAS BIGGER, JR, M.D.t Associate Professor of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York HAROLD C. STRAUSS, M.D., C.M.t Associate in Pharmacology, College of Physicians and Surgeons, Columbia University, New York, New York The function of the sinoatrial node is com­ ence with the extracellular fluid and often shows plex. In nearly all hearts, this small bit of tissue is some overshoot, that is, the inside of the cell may responsible for spontaneously generating the impulse become slightly positive relative to the extracellular which will be distributed to the remainder of the potential. After reaching this peak inside-positive heart, maintaining coordinated electrical and me­ value of transmembrane voltage (V111 ), the sinus chanical function. In recent years, it has become node cell slowly repolarizes to a maximum inside­ clear that S-A node dysfunction is not rare, can negative value-so-called maximum diastolic volt­ cause disabling symptoms, and often presents diffi­ age. Then, the transmembrane voltage spontaneously cult management problems. The challenges pre­ begins to decrease ( phase 4 depolarization) until sented by the "Sick Sinus Syndromes" have in­ a critical value of V 111 , threshold voltage, is reached creased our desire to know more about normal and self-excitation recurs. The rate of recurring S-A node function and about function in disease self-excitation could theoretically be altered by states. changes in: 1) maximum diastolic voltage, 2) The intimate mechanisms of sinus node func­ threshold voltage, and 3) rate of phase 4 depolari­ tion remain a mystery despite the "prying eye" of the zation.
    [Show full text]
  • The Heart in Portuguese Amyloidosis
    Postgraduate Medical Journal (1986) 62, 601-605 Postgrad Med J: first published as 10.1136/pgmj.62.728.601 on 1 June 1986. Downloaded from The heart in Portuguese amyloidosis A. Falcao de Freitas School ofMedicine, Oporto University, 4200 Porto, Portugal. Summary: A systematic investigation was performed in patients with familial amyloidotic poly- neuropathy, Portuguese type (AFp) to assess the pattern and incidence of cardiac involvement. Of 327 patients investigated, ECG abnormalities were present in 285 (87.2%). Low voltage and QS pattern in V1, V2, V3 were found in 51.3% and 35.7% patients respectively. Conduction disturbances were present in 211 (64.5%). Sinus node disease, 1st degree and Wenckebach interventricular blocks were frequent. Complete atrioventricular block was observed in only 2 patients (0.6%). Left anterior hemi-block was present in 30.8%, left bundle branch block in 3.9%, left posterior hemi-block in 2.4% and right bundle branch block in 2.1%. Holter monitoring showed a much higher incidence of conduction disturbances, most of these occurring at night. The mean values of septum and posterior wall thickness and mass evaluated by echocardiography in 72 patients were normal. The systolic and diastolic global and regional functions, determined in 12 patients, analysing the echo by a digitization computer technique, were normal. In 7% a trivial pericardial effusion was observed. In 16 patients with ECG changes and normal echocardiograms the technetium 99m pyrophosphate scanning was negative. We conclude that the ECG is the most precise, sensitive and clinically useful method for detecting cardiac amyloidosis in patients with AFp.
    [Show full text]